Pancreatic Cancer Research

ResearcherFujian Medical UniversityNo recent work listed

Dongliang Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5536-8468; OpenAlex author ID A5100323857. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2022: 2 papers · 2023: 1 paper

Papers 3

  1. Correction: Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients. Co-author DOI 10.1186/s12885-023-10504-2↗
  2. Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients. Co-author DOI 10.1186/s12885-022-10450-5↗
  3. Overexpression of OAS1 Is Correlated With Poor Prognosis in Pancreatic Cancer. Last author DOI 10.3389/fonc.2022.944194↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhongyuan Cui · 2 shared papers, 2022–2023 · strength 0.32
  2. Zhixian Wu · 2 shared papers, 2022–2023 · strength 0.32
  3. Gang Chen · 2 shared papers, 2022–2023 · strength 0.32
  4. Lingling Lu · 1 shared paper, 2022 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.